Quest Diagnostics
Quest Diagnostics Incorporated, a leading provider in the diagnostic testing industry, is headquartered in the United States. Founded in 1967, the company has established itself as a pivotal player in laboratory services, offering a comprehensive range of diagnostic information services that include clinical laboratory testing, anatomic pathology, and genetic testing. With a strong operational presence across North America, Quest Diagnostics is renowned for its commitment to innovation and quality, providing unique solutions that enhance patient care. The company has achieved significant milestones, including advancements in molecular diagnostics and a robust network of patient service centres. Recognised for its market leadership, Quest Diagnostics continues to set the standard in the healthcare sector, delivering reliable and accurate testing services that empower healthcare providers and patients alike.
DitchCarbon Score
How does Quest Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quest Diagnostics's score of 25 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Quest Diagnostics's reported carbon emissions
In 2022, Quest Diagnostics reported significant carbon emissions, totalling approximately 288,624,000 kg CO2e for Scope 1 and about 104,080,000 kg CO2e for Scope 2 in the US. The company's global emissions for the same year included approximately 107,228,000 kg CO2e for Scope 1 and about 859,000 kg CO2e for Scope 2, alongside approximately 820,410,000 kg CO2e for Scope 3 emissions. Over the years, Quest Diagnostics has demonstrated a commitment to reducing its carbon footprint. In 2021, the company achieved a notable reduction in Scope 1 emissions, dropping to approximately 238,910,000 kg CO2e from previous years. However, there are currently no specific reduction targets or climate pledges disclosed, indicating a potential area for future commitment. The company’s emissions profile reflects a substantial reliance on Scope 3 emissions, which accounted for a significant portion of their total emissions, highlighting the importance of addressing upstream and downstream activities in their climate strategy. As the healthcare industry increasingly focuses on sustainability, Quest Diagnostics is positioned to enhance its climate commitments and reduction initiatives in the coming years.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2015 | 2016 | 2017 | 2018 | 2021 | 2022 | |
|---|---|---|---|---|---|---|
| Scope 1 | 83,929,000 | 00,000,000 | 000,000 | 000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 145,724,000 | 000,000,000 | 000,000 | 000,000 | 000,000,000 | 000,000 |
| Scope 3 | 41,299,000 | 00,000,000 | 000,000 | 000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quest Diagnostics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
